Dr. Kuebler Receives David King Community Clinical Scientist Award
ROCKVILLE, MD – J. Philip Kuebler, MD, PhD, was honored with the Association of Community Cancer Centers’ annual David King Community Clinical Scientist Award. Dr. Kuebler is medical director for oncology research at Riverside Methodist Hospital in Columbus, Ohio, and principal investigator of the Columbus Community Oncology Program.
Dr. Kuebler was honored at ACCC’s 33th Annual National Meeting on Thursday, April 3, 2008, in Baltimore, Md. The David King Community Clinical Scientist Award recognizes active community clinical research leaders. Award winners have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.
Dr. Kuebler has focused on colorectal cancer research for much of his career. He helped to expand the Columbus Community Clinical Oncology Program to include most of central and southern Ohio and grow to 16 institutions, and some 90 oncologists and 30 research nurses. In 2006 Dr. Kuebler was elected to serve on the National Cancer Institute (NCI) Gastrointestinal Steering Committee, which now approves all phase III trials in GI cancer sponsored by the NCI.
Today he serves on the Executive Working Group for Colorectal Cancer in the National Surgical Adjuvant Breast and Bowel Project (NSABP), and is participating in the design of future phase III trials within the group. He is collaborating in the design of a tissue-based study to develop a DNA signature that will predict patient sensitivity to various front-line regimens in metastatic colorectal cancer.
ACCC’s prestigious award is named after David K. King, MD, FACP, who passed away after a brief battle with cancer. Dr. King had a long and colorful history with the Association of Community Cancer Centers, serving in many capacities—President, Chair of ACCC’s Annual Presidents’ Retreat, and Co-Chair of ACCC’s reimbursement committee, just to name a few. Dr. King spent his entire life caring for individuals with cancer and advocating for access to quality care, while also championing the Community Clinical Oncology Program and the value of clinical research in the community setting. Award winners become lifetime members of the ACCC National Academy of Community Oncology Scientists, which will serve as a valuable resource to ACCC, NCI, pharmaceutical companies, and other organizations involved in community cancer research.
ACCC provides a national forum for addressing issues that affect community cancer programs, such as regulatory and legislative issues, measurements of the quality of care, and clinical research. Its unique membership of more than 650 hospital cancer programs and oncology private practices includes all members of the cancer care team: medical and radiation oncologists, surgeons, cancer program administrators and medical directors, pharmacists, oncology nurses, oncology social workers, and cancer program data managers. For more information, visit ACCC’s website at www.accc-cancer.org. |
